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Background: The HbN ofMycobacterium tuberculosis carries a potent nitric-oxide dioxygenase activity despite lacking a
reductase domain.
Results: The NADH-ferredoxin reductase system acts as an efficient partner for the reduction of HbN.
Conclusion: The interactions of HbN with the reductase are modulated by its CD loop and the Pre-A region.
Significance:Thepresent study provides new insights into themechanismof electron transfer during nitric oxide detoxification
by HbN.
Many pathogenic microorganisms have evolved hemoglobin-
mediated nitric oxide (NO) detoxificationmechanisms, where a
globin domain in conjunctionwith a partner reductase catalyzes
the conversion of toxic NO to innocuous nitrate. The truncated
hemoglobin HbN of Mycobacterium tuberculosis displays a
potent NO dioxygenase activity despite lacking a reductase
domain. The mechanism by which HbN recycles itself during
NO dioxygenation and the reductase that participates in this
process are currently unknown. This study demonstrates that
the NADH-ferredoxin/flavodoxin system is a fairly efficient
partner for electron transfer toHbNwith an observed reduction
rate of 6.2 M/min1, which is nearly 3- and 5-fold faster than
reported for Vitreoscilla hemoglobin and myoglobin, respec-
tively. Structural docking of the HbN with Escherichia coli
NADH-flavodoxin reductase (FdR) together with site-directed
mutagenesis revealed that the CD loop of the HbN forms con-
tactswith the reductase, and thatGly48mayhave a vital role. The
donor to acceptor electron coupling parameters calculated
using the semiempirical pathwaymethod amounts to an average
of about 6.4 105 eV, which is lower than the value obtained for
E. coli flavoHb (8.0 104 eV), but still supports the feasibility of
an efficient electron transfer. The deletion of Pre-A abrogated
the heme iron reduction by FdR in the HbN, thus signifying its
involvement during intermolecular interactions of theHbN and
FdR. The present study, thus, unravels a novel role of the CD
loop and Pre-A motif in assisting the interactions of the HbN
with the reductase and the electron cycling, which may be vital
for its NO-scavenging function.
Hemoglobins (Hbs) and flavohemoglobins (flavoHbs) are
employed as the first line of defense bymany pathogenic organ-
isms to disarm the toxicity of macrophage-generated nitric
oxide (NO) during intracellular infection (1–3). Truncated
hemoglobin, HbN, ofMycobacterium tuberculosis (Mtb)2 pro-
tects its host from the toxic effects of NO due to its potent
O2-dependent NO dioxygenase (NOD) activity (4–6). The
HbN-deficient strain of Mycobacterium bovis displays extremely
low NOD activity and lacks respiratory protection from NO as
compared with the native strain (5), suggesting that the pres-
ence of HbN contributes to the survival ability of Mtb in the
NO-enriched environment of macrophages (6). Raman spec-
troscopy revealed that heme iron coordination in MtbHbN is
well suited for performing O2/NO chemistry for NO dioxygen-
ation (7), which ismodulated by twounusual structural features
of the HbN: a 12-residue long highly flexible N-terminal Pre-A
region that is required for the optimal NOD activity (8), and a
protein tunnel system composed of short and long branches (9)
that facilitates ligand entry to the distal heme site (9, 10). The
functional role of the tunnel has been underlined in a dual path
mechanism for ligand access to the heme cavity (11), in which
binding of O2 to the heme triggers dynamical alterations in the
protein backbone that regulate the opening of the long branch
via a phenylalanine gate (Phe(E15)) (11, 12), thus facilitating
access of NO to the O2-bound heme.
Bacterial and yeast flavoHbs, acting as NO-dioxygenase
enzymes, are endowed with heme and flavin binding domains
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where (i) in a first step the oxyferrous heme interacts with NO
tomake nitrate and ferric heme, and (ii) subsequently the flavin
domain shuttles an electron fromNADH to the heme, which is
converted to the ferrous state, thus enabling the protein to start
the cycle again (1, 13, 14). The efficiency of the NOD function
depends on both oxidative and reductive reactions (13, 14). The
structural elements that determineNOD function are related to
the stabilization of O2 into the deoxygenated heme, a fast
migration of NO to the heme cavity, and its interactions with
heme-boundO2, and a rapid electron transfer from an electron
donor to recover the active ferrous state to start the fresh cycle
(1, 15, 16). Although other members of the Hb superfamily can
catalyze NO dioxygenation when paired with a suitable elec-
tron donor (17–19), all of them are not equally efficient (13).
The lack of an integrated reductase diminishes the ability of
many single domain Hbs and myoglobins (Mbs) to drive the
NO dioxygenation cycle (16, 17), as noted in the poor NO oxi-
dation activity of human Hb and sperm whale Mb (NOD rate
constants, kNOD, of89 and 43M1 s1, respectively) (16, 20).
Furthermore, the partner reductases compatible to various oxi-
dized Hbs and Mbs and their mechanisms for the electron
transfer remain poorly defined. Unlike many single domain
Hbs, the catalytic efficiency of NO dioxygenation (oxidative
half) by MtbHbN is significantly high (kNOD  745 M1 s1)
and compares well with two-domain flavoHbs that include a
reductase domain (1, 5). Therefore, it is intriguing how Mtb-
HbN carries out the NOD function so efficiently, because the
electron transfer event, which depends on the structural and
functional compatibility with a cognate reductase, might limit
the overall rate of NO dioxygenation. Any information on a
partner reductase that can efficiently catalyze the reduction of
theMtbHbNand themolecular determinants of the interaction
between theMtbHbN and reductase is not available so far.
Because MtbHbN is functionally active in Escherichia coli,
Salmonella enterica Typhimurium, and Mycobacterium smeg-
matis and allow these hosts to metabolize NO and resist nitro-
sative stress (4, 6, 8), it must be able to utilize heterologous
reductases to carry out NO dioxygenation, although this pro-
cess may not be specific to its native reductase system. Indeed,
it can be argued whether the crucial role played byMtbHbN for
the survival of the bacillus requires the expression of a specific
reductase partner, which to the best of our knowledge has not
been identified as yet. For efficient electron cycling, the reduc-
tase might simply require a precise coordination and structural
alignment with the globin domain, so that the cofactor (heme
and FAD) binding regions lie at a permissible distance for facile
electron flow. Accordingly, it seems reasonable to hypothesize
thatMtbHbN may establish transient interactions with one or
more partners depending on their structural and functional
compatibility. In this context, it is important to identify reduc-
tases that carry out the reductive process of MtbHbN and the
amino acid residues or regions involved in recognition and
binding to a reductase partner.
In the absence of any information on the specific reductase
partner involved in NOD function inMtb and hence the mech-
anism of electron cycling, this study addresses the challenging
question of the enzymatic reduction ofMtbHbN by examining
the feasibility of the reductive half-reaction for a set of reduc-
tases. Here we demonstrate that NADH-ferredoxin reductase
(FdR) catalyzes efficiently the reduction of ferric MtbHbN
required for its NOD function. Detailed spectroscopic and
structural studies have unraveled the mechanism by which
MtbHbNmay establish the intermolecular alliance with a com-
patible reductase partner. The interaction involves its flexible
CD loop region and is dependent on the dynamical motion of
the protein backbone, which is modulated by its N-terminal
Pre-A region.
EXPERIMENTAL PROCEDURES
Strains, Plasmids, and Culture Conditions—E. coli strains
JM109 and BL21DE3 were used routinely for cloning and
expression of recombinant genes. Bacterial cultures were
grown in Luria-Bertani (LB) or Terrific Broth (containing 24 g
of yeast extract, 12 g of Bacto-tryptone, 12.54 g of K2HPO4,
2.31 g of KH2PO4)mediumat 37 °C at 180 rpm.When required,
ampicillin and kanamycin (Sigma) were added at concentra-
tions of 100 and 30 g/ml, respectively. Plasmids, pBluescript
(Stratagene), and pET28c (Novagene) were used for cloning
and expression of the HbN encoding gene of Mtb and its site-
directedmutagenesis as described earlier (4, 8). Construction of
the Pre-A-deleted mutant of HbN (HbNPre-A) has been
reported earlier (8). The oligonucleotides were custom synthe-
sized by Essence Life Sciences, India.
Cloning, Expression, and Purification of Reductases and HbN
Reductase Chimeras—Reductase encoding genes of Mtb and
E. coli were amplified from the genomic DNA by a standard
PCR method using gene-specific forward and reverse primers,
designed on the basis of their known coding sequences. Genes
for the Mtb reductases TrxB (Rv3913), KshB (Rv3571), as well
as the E. coli NADH-flavodoxin reductase (FdR, Ec948414)
were amplified by PCR, authenticated by nucleotide sequenc-
ing, and expressed under theT7promoter of pET28c.Wild type
andHbNmutants were purified by ion exchange chromatogra-
phy (DEAE-Sepharose, Sigma), equilibratedwith 10mMTrisCl
(pH 8.0) and eluted using NaCl gradient, as mentioned previ-
ously (13).
HbN reductase chimeras HbN-KshB and HbN-FdR were
also generated. To this end, the reductase domain was attached
to theC-terminal portion ofMtbHbNwith the help of a 12-res-
idue long linker (-GTASVLKAIDTG-) carrying two glycine res-
idues to allow sufficient flexibility for the interactions between
HbN and the reductase. To generate the chimera, first the HbN
and the reductase encoding genes were amplified separately by
PCR. Three overlapping primers (5-TGATGCTGTTCCGAC-
TGGTGCCGTGGT-3; 5-CGCTTTCAGTACTGATGCTG-
TTCC-3; 5-ACCGTAGAATTCTCCCGTGTCAAT-3) en-
coding the linker region and carrying a EcoRI restriction site at
the 3-end were incorporated at the C terminus of the glbN
gene by standard overlappingPCR.The linker carrying the glbN
gene was then joined with different reductase encoding genes
via the EcoRI site and expressed under the T7 promoter of
pET28c. Reductases and HbN chimera were purified by nickel-
nitrilotriacetic acid affinity chromatography using the manu-
facturer’s protocol. Expressions of recombinant proteins were
visualized on a 15% SDS-PAGE. Redox states of proteins were
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checked spectrophotometrically by recording the Soret and
peaks.
Isolation of Glycosylated HbN from the HbN Overexpressing
Mtb—The HbN was overexpressed as a His-tagged protein in
M. tuberculosis H37Ra and purified as described previously
(21). Briefly, HbN expressing cells of Mtb were collected by
centrifugation and suspended in 10 mM TrisCl (pH 7.8) with
lysozyme (10 g/ml) to incubate at 37 ºC for 30 min. The cell
suspension was then lysed with French Press and HbN was
purified by metal affinity chromatography following standard
procedures.
Measurements of Kinetics of the HbN Reduction—The assay
developed by Hayashi et al. (18) was used here with a slight
modification as described elsewhere (13). Briefly, the reaction
was set up in a sealed cuvette chamber carrying a reaction mix-
ture consisting of different concentrations of oxidizedHbNand
NADH in a 0.1 M phosphate buffer (pH 7.2) saturated with CO.
The reactionwas initiated by adding the reductasewith the help
of a gas tight Hamilton syringe. The time course for the shift of
the Soret peak from 406 nm (oxidized form) to the reduced
formof heme (resulting binding of CO)was recorded at 420 nm
and reduction of FADwas followed at 460 nm.The difference in
absorbance between ferric and CO-bound species of HbN was
plotted with respect to time to calculate the initial velocity of
the reaction.
Measurement of Cofactors and NO Oxidation Profile of HbN—
The heme content of cells was measured by the procedure
described earlier (4, 22). Briefly, heme proteins were re-sus-
pended in 2.2 M pyridine, in 0.1 N NaOH. Heme concentrations
were determined by measuring the difference in absorption
spectra at 556 and 539 nm for dithionite-reduced and ferricya-
nide-oxidized protein, respectively. FAD content of proteins
was checked as described elsewhere (23). Briefly, the flavin
cofactor of the protein was extracted after boiling for 5min and
centrifugation at 14,000  g. FAD content was determined
through fluorescence at 520 nmwith excitation at 460 nmusing
an extinction coefficient of 11.6 mM1 cm1. Titration of oxy-
genated MtbHbN and its mutants by NO was checked essen-
tially as described earlier (8, 12), and profiles of NO-induced
oxidation were recorded after each addition of NO for the con-
version of oxygenated HbN into the oxidized state.
Structural Docking of MtbHbN and FdR—The x-ray struc-
ture of FdR from E. coli (PDB code 1FDR; 1.7-Å resolution) (24)
andMtbHbN (PDB code 1IDR, chain A; 1.9-Å resolution) (11)
were used to generate the three-dimensionalmodels of the pro-
tein-protein complex with ClusPro2.0 (25). First, a rigid body
docking was performed with PIPER (26), a program that relies
on the Fast Fourier Transform-based approach used with pair-
wise interaction potentials. The top 1000 ranked solutions
obtained fromPIPERwere then processedwith ClusPro, a clus-
tering algorithm that groups the solutions using the root mean
square deviation between solutions with a cut-off of 9 Å.
Finally, the generated models were classified according to the
weight of different coefficients as balanced, electrostatic
favored, hydrophobic favored, and van der Waals electro-
static favored. Choice of the final model was made on the basis
of the lowest energy using the balanced ClusPro score (25, 26),
the solution with the highest cluster members, and the lowest
distance between the heme prosthetic group in MtbHbN with
respect to the flavin cofactor in FdR, and further validated by
visual inspection of the contacts at the protein-protein
interface.
Molecular Dynamics Simulations—The three-dimensional
structural model of the HbN-FdR complex was refined by
means of extended molecular dynamics (MD) simulation (0.5
s) performed with the PMEMD.cuda module of the
AMBER12 suite (27) using the parm99SB force field (28). The
heme parameters were developed and thoroughly tested in pre-
vious works (29, 30). Parameters for the FAD cofactor were
taken fromAntony et al. (31), although the atomic chargeswere
assigned by fitting the atomic point charges to the B3LYP/6–
31G(d) quantum mechanical electrostatic potential using the
RESP method (32).
To set up the systems for MD simulations, the complex was
immersed in a pre-equilibrated octahedral box of TIP3P (33)
water molecules and counterions were added to maintain the
neutrality of the simulated system. The final system contained
the protein, 6 Na cations, and around 23,400 water molecules
(76,200 atoms). The equilibration protocol consisted of per-
forming an optimization of the initial structures, followed by
slow heating to the target temperature (298K). The heatingwas
performed in 2-ns MD at constant volume, followed by 2-ns
MD at constant pressure (1 bar). Once the equilibration was
completed, the system was simulated in the NPT ensemble
using periodic boundary conditions, the SHAKE algorithm (34)
to constrain the bonds connecting hydrogen, and heavy atoms
in conjunction with a 1-fs time step for the integration of New-
ton’s equations with a Langevin collision frequency of 2 ps1
(35), particlemesh Ewald for electrostatic interactions (36), and
a cutoff of 10 Å for noncovalent interactions. Frames were col-
lected at 10-ps intervals for subsequent analysis of the
trajectory.
Electron Transfer Pathway—The semiempirical pathway
method was used to identify the most plausible pathway for
electron transfer (ET) between the heme group and the FAD
isoalloxazine ring, as estimated using the algorithm developed
by Beratan et al. (37, 38). Briefly, the method looks for the path
that exhibits the highest donor to acceptor electron coupling
(HAB). For a given path, HAB is computed as the product of a
number of steps, each with a given coupling value, that defines
the pathway. A step can either be through atom, when two
orbitals share an atom, which are assumed to have a coupling
value of 0.6, and through space, when orbitals are separated by
empty space, for which the coupling is assumed to decay expo-
nentially with the orbital-to-orbital distance by using a decay
factor of 1.7. The HAB value (in eV) is finally obtained by
multiplying the obtained decay factor for the best ET path by 1
eV, which is the default value in the algorithm. This value rep-
resents in a qualitative way the feasibility for the electron trans-
fer process for a given path.
To obtain a proper description of the system, minor adjust-
ments of the parameters used in the pathway algorithm were
required. First, all orbitals of the heme iron were considered to
be equivalent. Second, couplings between all porphyrin and
FAD isoalloxazine ring located orbitals were set to one to repro-
duce their resonant character. Calculations were performed for
Enzymatic Reduction of Hemoglobin N ofM. tuberculosis
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snapshots taken at 10-ps intervals during the whole MD simu-
lation. This strategy has been successfully used in previous
works to study the role of protein fluctuations on the ET path-
ways in several systems, including heme and FAD containing
proteins (39–41).
Peptide Synthesis—To design the peptide for the CD loop
region, the interface between globin and the reductase was
examined, paying attention to the placement of the hydropho-
bic and hydrophilic residues at the interaction site. On the basis
of this information, a database of venom peptides (42) was
scanned to identify peptides that can be effective in disrupting
the interactions of the CD loop due to its composition of
hydrophobic and hydrophilic residues. One of the peptides
(ASMSECDPAEHCTGQSSECPADVFHK) was selected to
check its specificity for masking the CD loop and interrupting
the ET, whereas keeping unaffected both the oxygen binding
and NO oxidation properties of the HbN. Furthermore, a
nonspecific peptide with a randomly generated amino acid
sequence (EDAQIQVTYYDKAEKDYVTKS) was used as a
control. The peptideswere synthesized using the IMTECHsyn-
thesis facilities by automated solid phase peptide synthesis
using the 9-fluorenylmethoxycarbonyl-tert-butyl (Fmoc/tBu)
strategy. The peptides were purified through high performance
liquid chromatography (HPLC) and their identity was con-
firmed bymatrix-assisted laser desorption ionization (MALDI)
mass spectrometry.
RESULTS
Interactions of Mtb HbN with Native and Heterologous
Flavoreductases—Because NADP-ferredoxin/flavodoxin reduc-
tase systems are known to reduce met-Hb into the ferrous state
(43) and similar reductase modules are found naturally fused
with globins in two-domain flavoHbs, a series of flavoreductase
systems were selected for testing the enzymatic reduction of
MtbHbN. Two different flavoreductases ofMtb, e.g. KshB, and
TrxB and NADH-ferredoxin reductase (FdR) of E. coli that
exhibits sequence/structural similarity to the reductase domain
of flavoHbs were taken up for testing their potential for the
reduction of HbN. This assay exploits the ability of Hbs to form
a CO-adduct in its ferrous state, giving a specific Soret peak at
420 nm after conversion of Fe3 to Fe2 in the presence of a
compatible redox partner. Accordingly, the efficiency of Mtb-
HbN reduction was monitored spectrophotometrically by the
shift and increase in the Soret peak from 406 to 420 nm due to
formation of the CO adduct of HbN in the presence of different
reductases.
The efficiency of the redox state change inMtbHbNvaried in
the presence of different reductases. Among these, FdR of
E. coliwas found to be the most effective (Fig. 1A), whereas the
HbN reduction byTrxB andKshBwas very slow in the presence
of NADH. The rate of heme iron reduction in the HbN by FdR
was estimated as 6.2 M/min1 (Table 1). At 250 M NADH,
the optical spectrum of the flavin changed very fast and nearly
reached the fully reduced state in less than 30 s, whereas it
remains partially reduced at lower concentrations (Fig. 1B).
Therefore, reactions of the HbNwith different reductases were
checked at the steady state level of reduced flavin during the
phase when the absorbance at 460 nm reached the plateau. In
the presence of 250MNADH, a rapid decrease occurred at 460
nm due to FAD reduction in the presence of all three flavore-
ductases (Fig. 1B), indicating rapid reduction of FAD and initial
production of FADH2. Despite that reduction of the HbN still
occurred very slowly in the case of KshB and did not occur at all
in the case of TrxB (Fig. 1A), suggests that the ET from FAD to
FIGURE 1. Reduction profile of oxidized HbN in the presence of different
reductases. A, kinetic traces of the absorbance change at 420 nm for the
reaction between ferric HbNwith flavoreductases associatedwith binding of
CO to ferrous HbN. Oxidized HbN (8 M) was mixed with flavoreductases (1
M) in the presence of 250 M NADH and CO. Shift in the Soret peak of oxi-
dized HbN (406 nm) to 420 nm (CO adduct formation) was recorded at differ-
ent time intervals. B, profile of FAD reduction by NADH during interactions of
ferric HbNwith flavoreductases. Absorbance change at 460 nmwas recorded
for the reduction of FAD.
TABLE 1
Kinetic parameters for in vitro heme reduction of MtbHbN and its
mutants
Protein
complex Km kcat
Heme iron
reduction Ref.
M min1 M/min
HbN-FdR 19.9 13 6.2 This study
HbN-KshBa This study
HbNS47W-FdR 20.9 9.9 5.1 This study
HbNG48I-FdR 19.4 8 4.2 This study
HbNT49W-FdR 20.0 13.2 6.2 This study
HbNPre-A-FdR 16.3 1.5 0.9 This study
VHbb-FdR 12.4 7 2.2 This study
Mb-FdR 15 3.5 1.3 Our estimation
Mb-FdR 17 5 2 13
aNot determined due to extremely slow reaction.
b VHb (Vitreoscilla hemoglobin) as reported elsewhere (19).
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the heme might be rate-limiting. These results indicated that
FdR is an efficient redox partner for the enzymatic reduction of
theMtbHbN.
Reduction of Glycosylated HbN by FdR—Because HbN is
post-translationallymodified by glycosylation in its native host,
Mtb (21), we further checked the reduction profile of glycan-
linked HbN isolated from the HbN overexpressing strain of
Mtb and compared its reduction profile with its unglycosylated
counterpart along with other single domain Hbs, e.g. Vitreos-
cilla hemoglobin (VHb) and myoglobin (Mb), using FdR as a
reductase partner. Traces of time course reduction of theseHbs
by FdR are shown in Fig. 2. The difference in absorbance
between ferric and CO-bound protein was plotted versus time
to calculate the initial velocity of the reaction (under the con-
ditions used in this study, the velocity was directly proportional
to the concentration of FdR). The reduction efficiency of gly-
can-linked HbN was found comparable with its unglycosylated
counterpart and nearly 3- and 5-fold higher than the reduction
of VHb and Mb, respectively (Fig. 2, Table 1). Kinetic parame-
ters of heme reduction by FdR for VHb and Mb are given in
Table 1.
Integration of a Reductase Domain with HbN and Construc-
tion of HbN Reductase Chimeras—Because the efficiency of
MtbHbN reduction varied significantly with different reducta-
ses, we selectedMtbKshB andE. coliFdR as representative slow
and fast acting reductases, respectively, to gain insight into the
mechanism of HbN reduction. To this end, the two reductases
were integrated individually at the C terminus ofHbN tomimic
the two-domain flavoHb-like structure. These chimeras were
created with the notion that covalent linkage between reduc-
tase and HbN will speed up the formation of close contacts
between heme and FAD binding regions, thus facilitating the
ET process. The HbN-KshB and HbN-FdR chimeras were
cloned, expressed, and purified. The purified proteins exhibited
expected masses of 54 and 42 kDa for HbN-KshB and HbN-
FdR, respectively, and conferred reddish tinge to the cell when
over-expressed in E. coli. The two chimeras were found associ-
ated with cofactors (heme and FAD) and their absorption spec-
tra resembled the oxy-form ofMtbHbN with the Soret peak at
414 nm and  and  peaks at 540 and 575 nm, respectively,
indicating the presence of a functional heme domain.
The reduction profiles of the HbN chimeras were deter-
mined by monitoring the change in absorbance at 460 nm for
the reduction of FAD, and 420 nm for the reduction of heme
and CO adduct formation, and compared with the profile
obtained for E. coli HMP. A fast decrease in the absorbance at
460 nm was observed for the two chimeras in the presence of
NADH (250 M), the reduction profiles being very similar to
the decrease obtained for the separate reductases (data not
shown). Moreover, they resembled the decrease observed for
E. coliHMP, indicating a rapid reduction of FADand formation
of FADH2 in all the cases. However, no distinct change was
observed at 420 nm for theHbN-KshB chimera,whereas a rapid
increase in absorbance at 420 nm due to the binding of CO to
the reduced heme was found for HbN-FdR (Fig. 3A). On the
other hand, the reduction of the ferric HbN-KshB chimera was
restored and the Soret peak shifted to 420 nm when FdR was
added in the reaction mixture (Fig. 3B). It is thus likely that the
heme andFADdomains are not in close contactwith each other
in the HbN-KshB chimera, thus allowing FdR to interact with
the heme domain of HbN-KshB.
FIGURE 2. Comparison of reduction profile of glycosylated HbNwith dif-
ferent single domain Hbs in the presence of FdR. Comparative reduction
profile of HbN, glycosylated HbN (HbN-gly), Vitreoscilla hemoglobin (VHb),
and Mb in the presence of FdR. The control reaction was set without adding
FdR.
FIGURE 3.ReductionofHbN-reductase chimera.A, autoreduction profile of
E. coli HMP, HbN-FdR, and HbN-KshB chimeras in the presence of 250 M
NADH. B, autoreduction of the HbN-KshB chimera in the presence of 250 M
NADH before and 10 min after the start of reaction when FdR was added.
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Molecular Docking and Identification of Reactive Configura-
tion of HbN-FdR—Due to the high efficiency in converting fer-
ric HbN to the ferrous species, FdR was chosen as a model
reductase to identify key molecular elements of the HbN struc-
ture involved in interaction with the reductase and electron
flow to ferric HbN. Docking was used to explore the interac-
tions betweenHbN and FdR that can place both heme and FAD
cofactors in a permissible distance for the ET using ClusPro2.0.
Of various possible protein-protein poses (Table 2), the most
probable one was selected on the basis of the largest number of
members in the cluster of docked solutions (120 poses), the
lowest energy as determined by using the balanced ClusPro
score (907.4; score units) and the shortest distance from the
geometrical centers of heme and isoalloxazine rings (18.3 Å). In
the docked pose the interaction primarily involves the CD loop
of HbN, which lies close to the C terminus of FdR. It is worth
noting that the docked structure resembles the crystal structure
of flavoHb (FHP) from Alcaligenes eutrophus (PDB entry
1CQX) with respect to the placement of two co-factor binding
regions and the nature of residues at the protein-protein inter-
face (data not shown).
Refinement of the docked pose was accomplished by means
of an extendedMD simulation, which confirmed the structural
integrity of bothHbNandFdR in the complex (Fig. 4). Thus, the
root mean square deviation of the backbone atoms along the
trajectory generally ranged from 1.0 to 2.0 Å for both FdR and
HbN (note that the highly flexible Pre-A and loop F regions
were excluded from the analysis for HbN). Nevertheless, the
relative position of the two proteins varied significantly along
the MD simulation, leading to a configuration that was stable
during the last 200 ns of the trajectory (Fig. 5A), in which the
distance between heme and flavin cofactors ranged from 6 to 9
Å, although contacts between the heme propionate and the
FAD isoalloxazine ring as short as 5Åwere transiently achieved
(Fig. 5B).
In the final structure (Fig. 4), close contacts in the complex
involve residues in helix B, the CD loop, and the beginning of
helix E and F-G regions of HbN with the last 40 residues in the
N-terminal segment of FdR, leading to an interface character-
ized by a solvent-accessible area of around 900Å2 (Fig. 5C). The
protein-protein interface is stabilized by hydrophobic contacts
between residues Leu36 and Met50 (HbN) with Pro339, Val342,
and Ala368 (FdR). Furthermore, additional stabilization is
afforded by up to five salt bridge interactions (Glu25–Arg362,
Glu29–Lys357, Asp39–Arg343, Arg52–Glu226, and Arg83 with the
phosphate  of FAD), which are distributed around the central
hydrophobic cluster. Finally, a series of polar residues in theCD
loop (Ser47, Thr49, and Asn50) fill the space between the heme
propionates and the isoalloxazine ring of FAD.
As a last remark, it is worth noting that the three-dimen-
sional model of the HbN-FdR complex locates the C terminus
of HbN and the N terminus of FdR pointing toward the same
region. Keeping in mind both the intrinsic flexibility of the last
eight residues in HbN (not seen in the x-ray structure) and the
length of the 12-residue long linker used to build up the chime-
ras, molecular modeling analysis (data not shown) showed that
the spatial proximity of the C and N terminus of HbN and FdR,
respectively, is consistentwith the efficient ET rate ofHbN-FdR
chimera, which should be capable of adopting the same three-
dimensional structure as obtained for the separate proteins.
An estimation of the electron transfer efficiency, given by the
electron coupling determined from the snapshots sampled
along thewhole trajectorywas found to be about 6.4 105 eV,
the highest value being 9.0 104. It is worth noting that these
values comparewell with the electron coupling reported for the
E. coli flavoHb (7.1 105 eV for the x-ray structure, and 8.0
104 eV from the snapshots sampled inMD simulations) (37), a
system that is known to cycle electrons very efficiently. The
slightly lower average value obtained for theHbN-FdR complex
possibly reflects the fact that ET involves a protein-protein
complex, whereas in E. coli flavoHb it involves the intramolec-
ular ET between domains in the same protein.
The polar residues in the CD loop, together with water mol-
ecules, have a major contribution to the ET pathways (Fig. 6A).
Thus, Ser47, Gly48, and water residues contribute to define the
ET pathway during the whole trajectory, they being involved in
around 28, 42, and 29% of the ET pathways. A series of repre-
sentative ET pathways sampled at the end of the trajectory are
shown in Fig. 6B. A detailed analysis of the pathways reveals
that the ET from the FAD isoalloxazine ring to the heme follows
three major pathways (Fig. 6B): (i) a direct transfer through the
backbone of Ser47 and/or Gly48 residues, (ii) assisted by a water
molecule prior to transfer to residues in the CD loop, and (iii)
directly through a water molecule. This latter pathway agrees
with the trends found for the ET in E. coli flavoHb (38), where a
water molecule was found to assist the ET from the isoalloxa-
zine ring to the heme (37). Nevertheless, it is worth noting that
calculations predict a large electron coupling even in the
absence of water molecules (about 5.0 105 eV), which high-
lights the critical role of the CD loop in assisting ET in the
HbN-FdR complex.
TABLE 2
Details of the docking results obtained using the balanced ClusPro
score (E 0.40Erep 0.40Eatt 600Eelec 1.00EDARS (21)) for the 10
most populated protein-protein complex clusters indicating for each
of them the distance between de centers of geometry of the heme
group inMtbHbN and the flavin group in FdR
Cluster Members Representative
Weighted
Score
Distance
Å
1 120 Center 608.0 18.3
Lowest energy 907.4
2 117 Center 606.5 29.6
Lowest energy 761.6
3 113 Center 627.5 21.7
Lowest energy 827.5
4 79 Center 686.6 34.5
Lowest energy 744.5
5 71 Center 584.6 20.5
Lowest energy 703.9
6 55 Center 588.3 28.2
Lowest energy 728.5
7 52 Center 605 24.2
Lowest energy 640.6
8 49 Center 586.5 19.5
Lowest energy 675.8
9 43 Center 701.8 41.5
Lowest energy 701.8
10 34 Center 607.8 19.4
Lowest energy 668.5
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Role of CD Loop of Mtb HbN in Protein-Protein Interactions
and Electron Transfer Pathway—To further confirm the role of
the CD loop in defining the interface between MtbHbN and
FdR, we designed a short peptide against the CD loop region,
anticipating that binding of the peptide at the interface region
of FdR will alter the electron flow. To check the specificity of
this peptide against the CD loop, a randomly designed peptide
was also used as a control to check any nonspecific effect on the
reduction of ferric HbN in the presence of FdR. In the presence
of the CD loop-specific peptide, the Soret peak of ferric HbN at
406 nm remained unchanged as compared with the control
reaction, inwhich this peptidewas not added. In contrast, when
a nonspecific random peptide was added in the reaction mix-
ture, ferric HbN was readily reduced in the presence of FdR as
observed by the shift in the Soret peak to 420 nm due to the
formation of the CO-adduct of HbN (Fig. 7A), signifying the
reduction of HbN.
Site-directed Mutagenesis of CD Loop of MtbHbN—Because
structural and MD simulation studies supported the involve-
ment of CD loop residues Ser47, Gly48, andThr49 in defining the
ET pathway, the role of these residues was further checked by
site-directed mutagenesis. Thus, Ser47, Gly48, and Thr49 were
mutated to Trp, Ile, and Trp, respectively, to generate HbN
mutants, HbNS47W, HbNG48I, andHbNT49W, and the efficiency
of these mutants for reduction of heme in the presence of FdR
was determined and compared with the wild type protein. As
shown in Fig. 7B, all mutants were less efficient thanMtbHbN
in formation of the CO adduct, this effect being specially rele-
vant for the HbNG48I mutant (see also Table 1). At this point, it
is worth noting that reduction of FAD remained unaltered dur-
ing interactions of themutants with FdR (data not shown), thus
suggesting that the lower efficiency in promoting the reduction
of ferric HbN reflects a less efficient ET from the reductase.
Pre-A Motif of MtbHbN Is Required for the Intermolecular
Electron Transfer in MtbHbN-FdR Complex—Previous studies
have shown that the Pre-Amotifmodulates the dynamics of the
MtbHbN backbone to carry out the NOD function, whereas its
deletion compromises the NOD function due to the hindered
backbone motion (8, 12). The main difference in the dynamics
of protein structure was observed around B and E helices and
the movement of CD and EF loop regions, suggesting that
Pre-A deletion may affect the intermolecular interactions of
HbN with FdR and the efficiency of HbN reduction. To check
this possibility we compared the ability of wild typeHbNand its
Pre-A-deleted mutant to be reduced in the presence of FdR.
Interestingly, the Pre-A-deleted mutant displayed extremely
slow conversion from Fe3 HbN to the Fe2 species, as
observed from assays of CO binding to the ferrous species (Fig.
8A). The Km (16.3 M) of the Pre-A mutant appeared slightly
lower than thewild typeHbNbut the heme reductionwas dras-
tically reduced, corresponding to 0.9 M1 s1.
To further substantiate that the Pre-A motif is modulating
the reduction ability of MtbHbN, we also deleted the Pre-A
region in the chimera of HbN-FdR. Separately, we also created
another chimera of HbN with the reductase domain of E. coli
HMP that exhibited highly efficient ET ability (data not shown
here) and then deleted the Pre-A region from the HbN-HMP
chimera. In both cases, reduction of the globin domain was
completely abrogated, indicating the requirement of Pre-A in
regulating the CD loop of HbN for establishing the intermolec-
ular contacts with the reductase for the catalytic electron
cycling required for NOD function (Fig. 8B).
DISCUSSION
A large number of two-domain flavoHbs and Hbs in associ-
ation with a suitable reductase are known to participate in NO
detoxification (1, 2, 44, 45). Despite lacking an integrated
reductase partner,MtbHbNdisplays an efficientNOD (kNOD
745M1 s1) that compareswell with flavoHbs (kNOD 800–
2400M1 s1) and is severalfold higher thanHbs andMbs (1).
The missing link in understanding the NOD function of the
MtbHbN,which is integral to its uninterruptedNODactivity, is
FIGURE4.Representative snapshotof thebinding interfacebetweenHbNandFdR.A, representationof the relativeorientationofHbNandFdR.B, detailed
view of selected interactions formed at the interface between the two proteins. The backbone of HbN and FdR is shown as cyan and yellow schematics,
respectively, and the heme and FADunits are shown as green andmagenta sticks. Residues that participate in salt bridge or hydrophobic contacts between the
proteins are shown as red and orange spheres, respectively. The part of the CD loop that partially fills the region between heme and FAD is shown in blue.
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the molecular mechanism by which HbN associates with a
reductase partner to replenish itself from a ferric to ferrous
state for the next cycle of NOD activity. The reductase(s) com-
patible for the reductive half of the HbN-mediated NOD reac-
tion is currently unknown.
To support the NOD function of MtbHbN, an efficient
reduction is required to guarantee the survival of Mtb. Our
results show that the reduction of MtbHbN is accomplished
with a wide range of efficiency for distinct reductases, varying
from the low enzymatic reduction triggered byMtb flavoreduc-
tases KshB and TrxB to the high efficiency of E. coli FdR. This
binary interaction may be similar to the mammalian mem-
brane-bound microsomal NADPH-cytochrome 450 reductase,
which is structurally related to ferredoxin reductase and partic-
ipates in NOD function together with single domain Hbs dis-
playing flavoHb-like properties (44). Thus, our results show
that theNOD function ofMtbHbN is not restricted to its native
electron donating partner. Indeed, it is retained during its
expression in various heterologous hosts (4, 6). Because ferre-
doxin/flavodoxin reductases are widely distributed in nature,
they may complement with the HbN for sustaining its NOD
function in a wide range of bacterial hosts.
During the reductive process, electrons are sequentially
transferred from NADH to FAD and then to the heme iron, as
has been demonstrated in the case of E. coli HMP (14) and
binary interactions of metHb with cytochrome b5 reductase
(16, 44, 45).WhenmetHbN interactedwithKshB andTrxB, the
reduction of FAD occurred rapidly with NADH in a concentra-
tion-dependent manner, whereas reduction of the heme iron
remained extremely slow. At 250 M NADH, when FAD was
completely bleached out, efficiency of heme reduction did not
change in the case of KshB and TrxB, thereby indicating that
the hydride transfer from NADH to FAD is not the limiting
step. In contrast, reduction of FAD and ferric HbN occurred
very efficiently in the presence of FdR. This process involves a
single turnover of HbN molecules with limiting FdR in its
reduced state that is cycled by NADH. Thus, the rate of HbN
reduction may vary with the concentration of reduced flavin in
each reaction mixture as a function of NADH concentration.
In an attempt to bring the heme and FAD cofactor binding
sites closer, HbN was integrated with KshB. However, the inte-
gration did not speed up the reduction process. Interestingly,
whenFdRwas added, it immediately enhanced the heme reduc-
tion in the HbN-KshB chimera, indicating that the heme and
FAD binding regions are not in close contact and allowing FdR
to interact with the heme binding region of HbN-KshB. In con-
trast, reduction of the heme iron occurred rapidly in the HbN-
FdR chimera, signifying that FdR encompass suitable structural
features compatible for the efficient reduction of theMtbHbN.
The three-dimensional structure obtained fromMD simula-
tions shows that the CD loop contributes to shape the protein-
protein interface near the isoalloxazine ring of the FAD. The
CD loop ofHbN carries polar residues (Ser47, Thr49, andAsn50)
that may participate in building transient contacts with the
partner to facilitate ET from the FAD to the heme.At this point,
it is worth noting that the distance between the propionate of
heme to the nearest atom in the isoalloxazine ring remains in
the range of 6–9 Å along the last 200 ns of the trajectory, which
compares with the distance found between those cofactors in
the flavoHb of A. eutropus (around 7 Å).
Because a dominant coupling pathway is expected to occur
when donor and acceptor are located at short distances (46, 47),
the large value of the electron coupling determined with the
semiempirical pathway method supports the feasibility of this
region in mediating the ET flow. Due to the presence of Gly48
the CD loopmight afford the intrinsic flexibility to facilitate the
adjustment of HbN at the protein-protein interface. The rele-
vance of the CD loop is supported by inhibition of MtbHbN
reduction by FdR in the presence of the CD loop peptide and by
decrease in the formation of the CO-adduct in the CD loop-
FIGURE 5. Time evolution of selected structural parameters of the HbN-
FdR complex. Time evolution (ns) of (A) the root mean square deviation
(RMSD; Å) determined for the backbone atoms of the HbN-FdR complex, (B)
the distance (Å) between the isoalloxazine ring (methyl group at position C8)
and one of the heme propionate groups, and (C) the accessible solvent area
(ASA; Å2) of the interface for the HbN-FdR complex.
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mutated variants ofMtbHbN. In particular, Gly48 appears to be
a major player in modulating the intrinsic flexibility of the CD
loop for the adjustment of the co-factor binding sites at the
interface for the smooth transfer. The flanking residues (Ser47
and Thr49) may also contribute in sustaining the appropriate
environment for the electron flow. At this point, it is worth
FIGURE 6. Representation of the major ET pathways. A, contribution of selected residues to the ET pathways. B, superposition of representative snapshots
togetherwith the associated ETpathways (shown in “orange”) from the FAD isoalloxazine ring to theheme in theprocess ofMtbHbN reduction. HemeandFAD
are shown as green andmagenta sticks. Residues in the CD loop are shown in blue.
FIGURE 7. Effect of CD-loop specific peptide and CD-loop mutation on
reductionofMtbHbNbyFdR.A, reductionofMtbHbN (8M) in thepresence
of CD loop-specific and nonspecific peptide (40 M) by FdR (1 M). A, control
reaction with HbN-FdR; B, HbN-FdR with CD loop peptide; C, HbN-FdR with
nonspecific peptide. B, reduction profile of HbN CD loop mutants by FdR
recorded as absorbance change at 420 nm due to conversion of ferric HbN
into ferrous state and binding of CO.
FIGURE 8. Reduction profile of (A) wild type and Pre-Amutant of HbN by
FdR and (B) autoreduction of HbN-FdR andHbNPre-A-FdR chimeras. The
graph depicts the efficiency of wild type and mutant HbN reduction as
recorded by the increase in the absorbance at 420 nm (Soret peak) due to the
formation of the CO-adduct after conversion of oxidized HbN into the
reduced state of MtbHbN and Pre-A-deleted HbN (HbNPre-A) (A) and HbN-
FdR chimera and Pre-A deleted HbN-FdR chimera (HbNPre-A-red) (B).
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stressing that the NO oxidation profile of the HbN mutants
remained unaffected (data not shown), signifying that the CD
loop may not be affecting the gating role of Phe(E15) and the
oxidative half of the HbN-mediated NOD function. It can then
be concluded that the CD loop has a crucial role in mediating
the reduction step betweenMtbHbN and FdR.
The structural information of the HbN-FdR complex also
allows us to explain the similar reduction efficiency exhibited
by glycosylated andunglycosylatedHbN in the presence of FdR.
Thus, the glycan moiety is linked at the C-terminal end of the
HbN and should not interfere with the interactions between
HbN and FdR. The present study has also unveiled a novel role
of the Pre-A motif of HbN, which is required for its optimal
NOD function by regulating the protein backbone motion and
to facilitate diffusion of NO toward the active site (8). In the
absence of Pre-A motif, the FdR was unable to reduce HbN
individually as well as in the HbN-FdR chimera. However, the
three-dimensional structure of theHbN-FdR complex does not
support a direct interaction with the Pre-A segment. Rather,
the large flexibility of the Pre-A region, which is modulated by
the ability to form transient electrostatic contacts with the pro-
tein core (8, 9), influences the dynamics ofHbN, and themotion
of the protein backbone changes significantly when Pre-A is
removed from the HbN. In particular, previous studies showed
that the Pre-A-deleted HbN displayed a clear cut restriction in
the movement of B and E helices as well as the EF loop region
(16), which in conjunction with the CD loop provides key resi-
dues involved in the recognition of HbN and FdR. It can, there-
fore, be concluded that the Pre-A segment influences the NOD
function bymodulating the dynamics of the protein core, which
in turn influences two distinct effects: (i) the relative motion
between helices B and E favors the conformational changes of
the Phe(E15) gate, thus favoring the transition between closed
and open states (8, 12), and (ii) the enhanced flexibility of heli-
ces B and E regulates movement of the CD loop and facilitates
the interactions between residues that modulate the appropri-
ate recognition at the protein-protein interface. Thus, the
results derived from MD simulations reveal the formation of
salt bridges supported by residues located in helix B (Glu25,
Glu29) andE (Arg52) aswell as beginning ofCD loop (Asp39) and
loop F (Arg83), which contribute to the interaction between
MtbHbN and FdR. The restricted motion of helices in the
Pre-A-deleted mutant of MtbHbN might have affected the
global flexibility of the protein matrix and abrogated its inter-
actionswith the reductase partner, leading to failure of the elec-
tron flow.
The HbN may have significant implications on the patho-
physiology ofMtb due to its high oxygen affinity andNOdetox-
ification ability, whichmay be crucial for sustaining its intracel-
lular survival within the NO-enriched hypoxic environment of
macrophages and granuloma. Although the HbN knockout
strain ofMtb has not been generated so far, lack of respiratory
protection from NO in the HbN-deleted strain of M. bovis (5)
suggests that the loss of HbN may significantly affect intracel-
lular survival of Mtb. We have demonstrated that Pre-A is
required for NO oxidation by HbN by modulating the dynam-
ical motion of the protein backbone required for ligand access
(8). This study highlights that the Pre-A is also involved in reg-
ulating the interaction of HbN with the reductase partner for
efficient cycling of NOD reaction. These results suggest that
both HbN and its reductase partner might be well suited as
targets for developing novel pharmacological strategies to fight
tuberculosis.
The present study thus unravels a novelmechanismbywhich
HbN interacts with a compatible redox partner to keep itself in
the functional ferrous state for oxygen binding and NO scav-
enging. Taken together, this work presents three major find-
ings: (i) enzymatic reduction ofMtbHbN via native and heter-
ologous flavoreductases occurs with varying efficiency and
among these, reductase structurally similar to NADH-ferre-
doxin/FdR may be an efficient partner for the ET that may be
vital for its oxygen binding andNO-scavenging function, (ii) the
CD loop of MtbHbN plays an important role in establishing
transient interactions with a partner reductase to facilitate the
ET, and (iii) the Pre-A motif regulates interactions of the CD
loop with the partner reductase and displays a larger effect on
ET, thereby substantiating the relevance of the Pre-A motion
on the dynamics of the protein backbone that may be essential
for enzymatic reduction ofMtbHbN.
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